Showing Results 1-7 of 7 |  Sort by:     
Page 1 of 1  |  Go to page   
CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones.rnrn***********************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer). rn
Threshold Pharmaceuticals...
Categories: Videos 
Added: 1 days ago
By: karmastock
Runtime: 1m34s
Views: 2
 | Comments: 0
Not yet rated
CRWENewswire, Stocks to Watch. GenVec Inc - GNVC - reported that it has extended its Research Collaboration and License Agreement with Novartis. Under the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program. In January 2010, GenVec entered into a worldwide licensing and collaboration agreement with Novartis to discover and develop novel treatments for hearing loss and balance disorders. According to the company, under the terms of the agreement, if certain clinical, regulatory, and sales milestones are met, GenVec is eligible to receive up to $213.6 million, including upfront and milestone payments in addition to royalties on future sales. GenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines.rnrn*********rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
GenVec (GNVC) Extends...
Categories: Videos 
Added: 7 days ago
By: karmastock
Runtime: 1m26s
Views: 18
 | Comments: 0
Not yet rated
Televiziunea Favorit l-a invitat din nou pe Eugen Ungureanu intr-un Show Muzical de mare clasa. A fost o atmosfera incredibila in care auditoriul a cantat si a dansat impreuna cu artistul. De asemenea melodia Tu Esti Cea Mai Frumoasa a urmat o promovare si o ascensiune puternica, ea fiind difuzata si reluata in fiecare zi, in asa fel incat auditoriul telespectator sa aiba posibilitatea de a o viziona, in cadrul rubricii Favoritii Sunteti Voi. Este inca odata confirmata audienta si calitatea interpretativa a lui Eugen Ungureanu care devine din ce in ce mai mult, un artist solicitat si prezent la manifestarile de tot genul, pe Radio si Televiziune, la petreceri private-inclusiv nunti, dar si la mari spectacole si Festivaluri asa cum a fost cel de la Popesti-Bihor, unde a avut pe langa calitatea de solist si aceea de prezentator, aplaudat de mii de oameni. Pentru contactarea solistului si prezentatorului Eugen Ungureanu, sunati la 0722.410.597 sau 0745.503.350 ori trimiteti e-mail la tvbucuresti@yahoo.comrnrn
Eugen Ungureanu invitat la...
Categories: Videos 
Added: 1063 days ago
By: electrostar
Runtime: 3m40s
Views: 181
 | Comments: 1
     
Eugen Ungureanu a fost si prezentatorul si artistul care cu deschiderea sa fata de public timp de 3 zile s-a bucurat de un mare succes. Mai exact Sarbatorile de Iarna de pe Valea Bistrei unde mii de spectatori au cantat impreuna cu el si au invatat refrenele tuturor melodiilor. De data aceasta va prezentam evolutia cu melodia latino Asa Sunt Fetele care face parte de pe primul album al indragitului cantaret. Extras din Ziar de Bihor-Lavinia Matei. Telefon pentru contactarea artistului in vederea participarii la Zilele Orasului sau Comunei – 0722.410.597 sau 0745.503.350
Eugen Ungureanu invitat la...
Categories: Videos 
Added: 1063 days ago
By: electrostar
Runtime: 4m36s
Views: 194
 | Comments: 1
     
Good Wednesday Morning, Its August 3rd, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. For its second quarter which ended June 30, 2011, SuccessFactors Incorporated - symbol SFSF - posted non-GAAP revenue of approximately $73.2 million, a 48 percent increase year-over-year and above the company's prior guidance. EDAP TMS - symbol EDAP - reported that it has received marketing clearance from the U.S. Food and Drug Administration (FDA) for its Sonolith i-move device, a technologically advanced compact mobile lithotripter for real-time, three-dimensional ultrasound localization of urinary stones. Global Traffic Network Incorporated - symbol GNET - has agreed to be bought by an affiliate of private equity firm GTCR for $14-a-share in cash. Thanks for joining me and have a great one! For CRWE Newswire, Stocks In Action, I’m Sara Bryant
(SFSF, GNET, EDAP)...
Categories: Videos 
Added: 186 days ago
By: karmastock
Runtime: 1m20s
Views: 84
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch for Friday December 23rd, 2011. I am Lynn Lumpkin. Eastman Kodak Co - EK - reported that has agreed to sell its Eastman Gelatine Corporation business to Rousselot, part of the Vion Food Group. For the fiscal year 2011, China Direct Industries Inc - CDII - posted revenue of $187.8 million, a 66.6% increase compared to fiscal 2010. and finally; According to a global collaboration agreement, Baxter International will make an upfront cash payment of $33 million to Momenta Pharmaceuticals Inc - MNTA - and may make additional payments over the next several years for the development of up to six follow-on biologic compounds, contingent upon the achievement of technical, development and regulatory milestones with respect to all six products. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Lynn Lumpkin
(EK, CDII, MNTA)...
Categories: Videos 
Added: 44 days ago
By: karmastock
Runtime: 1m25s
Views: 23
 | Comments: 0
Not yet rated
Good Morning, It’s Friday Jan. 06, 2012, I’m Lynn Lumpkin with CRWENewswire Stocks In Action. BioDelivery Sciences International Inc - BDSI - reported the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain. In aggregate, the agreement is worth up to $180 million to BioDelivery Sciences if all milestones are met. For the third quarter ended November 30, 2011, AZZ inc - AZZ - posted revenues of $116.5 million, a 13% increase year over year. and lastly; The Greenbrier Companies - GBX - reported Revenue of $398.2 million for the first quarter of 2012, double the Revenue realized in the same period the prior year. Thank you for joining me and have a great day! For CRWE Newswire, Stocks In Action, Lynn LumpkinrnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
(BDSI, AZZ, GBX)...
Categories: Videos 
Added: 30 days ago
By: karmastock
Runtime: 1m21s
Views: 18
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0442 seconds.